Literature DB >> 20577860

Levels of soluble CD14 and lipopolysaccharide-binding protein in human basal tears.

Ken Fukuda, Naoki Kumagai, Teruo Nishida.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577860     DOI: 10.1007/s10384-009-0787-z

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.

Authors:  David R Blais; Sandy G Vascotto; May Griffith; Illimar Altosaar
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

2.  Potentiation of lipopolysaccharide-induced chemokine and adhesion molecule expression in corneal fibroblasts by soluble CD14 or LPS-binding protein.

Authors:  Ken Fukuda; Naoki Kumagai; Kazutaka Yamamoto; Youichiro Fujitsu; Nobuhiko Chikamoto; Teruo Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

3.  Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts.

Authors:  Naoki Kumagai; Ken Fukuda; Youichiro Fujitsu; Ying Lu; Nobuhiko Chikamoto; Teruo Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-01       Impact factor: 4.799

4.  Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS.

Authors:  P Gallay; C Barras; P S Tobias; T Calandra; M P Glauser; D Heumann
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

5.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

  5 in total
  1 in total

Review 1.  Corneal Fibroblasts as Sentinel Cells and Local Immune Modulators in Infectious Keratitis.

Authors:  Ken Fukuda; Waka Ishida; Atsuki Fukushima; Teruo Nishida
Journal:  Int J Mol Sci       Date:  2017-08-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.